Reducing the frequency of eye screening in patients with diabetes from annually to every other year would delay detection of sight-threatening diabetic retinopathy (STDR) and proliferative diabetic ...

Please provide your email address to receive an email when new articles are posted on . Among diabetes care centers in India, screening for diabetic retinopathy using tele-ophthalmology proved ...

With this improved integration dedicated to portable AI screening, healthcare providers can now order exams and receive results in real time, enabling diabetic retinopathy (DR) screenings in under one ...

Please provide your email address to receive an email when new articles are posted on . Ford Medical will distribute AEYE-DS to U.S. pharmacies and non-acute centers. The system pairs with a retinal ...

SECAUCUS, N.J., April 4, 2022 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced a collaboration with IRIS (Intelligent ...

One-third of diabetic adults in the U.S. do not receive annual eye exams. Additionally, lack of pupillary dilation before exams is associated with ungradable, or insufficient exams. In September 2022, ...

AI-based retinal imaging and diagnostics startup AEYE Health announced today it received clearance from the FDA to market its diagnostic screening system for diabetic retinopathy. There are 35 million ...

The meta-analysis found insufficient evidence to assess the validity of the screening in diagnosing age-related macular degeneration. Teleretinal screening appears to be an accurate tool to identify ...

Implementation this month of a longer screening interval for diabetic eye disease for patients deemed 'low risk' could result in delays in critical hospital referral, researchers from a London-led ...

Despite its underutilization, AI-powered diabetic retinopathy screening was associated with greater OCT referral rates than traditional screening methods. Artificial intelligence (AI)-based diabetic ...

Artificial intelligence (AI)-based retinal image analysis detects sight-threatening diabetic retinopathy as accurately as human graders, but is not yet licensed in the National Health Service's ...